title: The legend of cytomegalovirus and glioblastoma lives on.
authors: michael.weller@usz.ch.
authors: Michael
authors: M
authors: Weller
authors: Riccardo
authors: R
authors: Soffietti
authors: Michael
authors: M
authors: Brada
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D002986:Clinical Trials as Topic / Q000592:standards*; D003587:Cytomegalovirus / Q000472:pathogenicity*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000821:virology; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005909:Glioblastoma / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D006801:Humans; D011379:Prognosis; D015996:Survival Rate; D000077562:Valganciclovir
chemical_list: D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir
keywords: CMV; bias; glioblastoma; trial; valganciclovir